NeoPharm Phase I/II starts

NEOL began U.S. Phase I/II trials of Liposome Encapsulated Mitoxantrone (LEM) in cancer. The Phase I part of the trial will test about 50 patients with solid tumors for maximum tolerated dose, accordi...